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Transtracheal jet ventilation 
in a porcine model
ABSTRACT
Hypoxemia is a frequent event during difficult airway management. We propose to use transtracheal jet ventilation (TTJV) 
early during the management of complex difficult airway scenarios. The objective of this porcine study is to highlight the 
benefit of oxygenation via prophylactic TTJV. Eighteen pigs (Sus scrofa) were divided into two equal groups. In Group A, 
pigs were anesthetized and no lung ventilation was conducted following administration of succinylcholine and prior to 
tracheal intubation. Group B, after induction of anesthesia, received transtracheal ventilation using 100% oxygen. In both 
groups intubation was performed after waiting 90 seconds. All intubations were achieved in less than 30 seconds. Post-
intubation arterial blood gases demonstrated significant hypoxemia in Group A (PaO
2
 22.6 + 5.8 mm Hg), while in Group 
B oxygenation substantially improved (PaO
2
 470.3 + 17.0 mm Hg). The arterial CO
2
 retention was associated with mild 
respiratory acidosis (pH 7.26 ± 0.05) in Group A only. These findings prove that prophylactic TTJV can improve oxygenation 
and allow extra time for definitive management of difficult airway.
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Introduction
During the management of difficult air-
way, hypoxemia is a major cause of 
morbidity and mortality. Maxillofacial 
trauma represents an especially difficult 
clinical scenario as the combination 
of airway bleeding, distorted airway 
anatomy, uncooperative patient and 
urgency to secure the airway creates a 
complex situation with limited options. 
The American Society of Anesthesiolo-
gists (ASA) 2003 Difficult Airway Algo-
rithm uses transtracheal jet ventilation 
(TTJV) as a near last option. (1) We 
recently reported the prophylactic use 
of TTJV during the management of dif-
ficult airway in two patients with neck 
and maxillofacial trauma. (2) Early use 
of TTJV can provide the anesthesiolo-
gist with the additional time necessary 
to prepare for definitive airway manage-
ment. This technique should be consid-
ered in selective patients who are com-
bative or uncooperative, or who have 
unusual anatomy, upper airway, facial, 
and head and neck trauma. Technical 
details of this procedure can be found 
in our recent report. (2) Once the jet 
catheter is placed in the trachea and 
the oxygen source is attached to the 
catheter, the patient can be sedated 
to allow for controlled and less urgent 
tracheal intubation by the most appro-
priate technique. In addition to main-
taining the patient’s oxygenation, TTJV 
helps the physician in identifying the 
airway as insufflated oxygen is exiting 
the glottis creating visible bubbling. In 
the presence of airway edema, exces-
sive secretions or blood in the airway, 
this gas escape may help in direct-
ing the endotracheal tube during either 
direct laryngoscopy or fiberoptic bron-
choscopy.
The objective of this porcine study is 
to highlight the benefit of oxygenation 
via prophylactic TTJV. We propose to 
initiate early TTJV for two reasons: first, 
to reduce the hypoxemia, and second, 
to allow more time for definitive airway 




With the approval of our Institutional 
Animal Care and Use Committee, fol-
lowing guidelines established by the 
National Institutes of Health for the Care 
and Use of Laboratory Animals, eigh-
teen pigs (species Sus scrofa) weigh-
ing 25 to 30 kg were divided into two 
groups, Group A and Group B. 
Pigs in Group A (n = 9), the control 
group, were induced with pentobarbi-
tal, 300 mg, followed by administration 
of succinylcholine, 60 mg, intravenously 
(IV).  After waiting 90 seconds to simu-
late a “difficult airway” scenario where 
ventilation is difficult or impossible, tra-
cheal intubation was performed in less 
than 30 seconds. In Group B (n = 9), the 
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animals received the same induction as 
pigs in group A. A 12-gauge catheter 
(Angiocath®, Deseret Medical Inc., 
Park Davis and Company, Sandy, UT) 
was placed percutaneously across the 
cricothyroid membrane into the trachea 
with local anesthesia. Subsequently, 
Group B pigs received transtracheal 
ventilation using 100% O2 at 50 psi at a 
rate of 15 breaths per minute with an I:
E ratio of 1:4 using a manually triggered 
jet ventilator (Instrumentation Industry, 
Inc., Bethel Park, PA). Tracheal intuba-
tion was performed after waiting 90 
seconds. Intubations were achieved in 
less than 30 seconds. In both groups, 
arterial blood gases were drawn from 
pigs before induction and immediately 
after intubation. Data are expressed as 
mean + standard deviation. The pre-
intubation and postintubation arterial 
blood gases were compared using a 
paired t-test, and the two groups were 
compared using an unpaired t-test. 
A value of P < 0.05 was considered 
significant. 
Results
Hypoxemia occurred in Group A (with-
out TTJV) at the end of a 90-second 
period of apnea (PaO2, 22.6 ± 5.8 mm 
Hg; baseline PaO2, 80.5 ± 4.7 mm 
Hg; P <0.0001, figure 1). In Group B, 
oxygenation improved during the 90-
second period of TTJV and the time 
required to intubate (PaO2, 470.3 ± 
17.0 mmHg; baseline PaO2, 83.6 ± 
4.2 mm Hg, P <0.0001, figure 1). While 
there was no difference between groups 
at baseline, the postintubation PaO2 
was significantly higher in pigs receiv-
ing TTJV (P <0.0001). In both groups, 
arterial carbon dioxide tension (PaCO2) 
increased (Group A: PaCO2, 60.5 ± 
4.9 mm Hg; baseline PaCO2, 41.44 ± 
3.71 mm Hg; Group B: PaCO2, 44.8 ± 
3.9 mm Hg; baseline PaCO2, 37.1 ± 
1.6 mmHg, figure 2). The arterial CO2 
retention in Group A was associated 
with a mild respiratory acidosis (pH 
7.26 ± 0.05). 
Discussion
The exact incidence of hypoxemia dur-
ing the management of difficult airway is 
not known but is presumed to be high. 
Mateer et al. studied emergency room 
endotracheal intubations and reported 
a 10.4% incidence of hypoxemia. (3) 
During difficult intubation the incidence 
of hypoxemia is likely to be even greater. 
In our study, we found a large decrease 
in arterial oxygenation after a 2-minute 
apnea; this hypoxemia was associ-
ated with hypercapnia (61 mmHg) and 
respiratory acidosis (pH 7.26) (figures 
1,2). In contrast, in animals receiving 
Figure 1. Control group (nonventilated pigs) became profoundly hypoxemic 
during apnea. Pigs in TTJV group had improvement in oxygenation during the 
2-minute period before tracheal intubation (P values were < 0.0001).
Figure 2. In control and TTJV groups, arterial carbon dioxide tension (PaCO2) 
increased during the 2-minute period, more so in non-ventilated animals 
(controls).
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fiberoptic intubation. Figure 3 depicts 
a modified maxillofacial trauma algo-
rithm (10) and demonstrates the posi-
tion within this algorithm we propose 
for preemptive use of TTJV in scenarios 
of complex difficult airway. TTJV may 
be equally helpful in gaining additional 
time while preparing for other options for 
invasive airway access (percutaneous 
tracheostomy and cricothyroidotomy). 
The use of TTJV is not without com-
plications. One of the most frequently 
described complications is dislodge-
ment of the catheter during TTJV which 
may result in subcutaneous emphysema. 
(11) This potentially catastrophic situa-
tion can convert the difficult airway into 
an “impossible airway.” Other complica-
tions of TTJV include bleeding, pneu-
mothorax, barotrauma, tracheal and 
esophageal perforation as well as life-
threatening intravascular misplacement 
of the catheter. (12-14) In addition, when 
TTJV was placed emergently instead 
of prophylactically, complications were 
twice as likely to occur. (11) In order to 
avoid these complications it is of the 
utmost importance to check the proper 
position of the catheter before the ini-
tiation of jet ventilation by confirming the 
ability of free-air aspiration with a large 
syringe. It is equally important to have 
a dedicated assistant who will keep the 
catheter secure in the position and who 
will be monitoring for signs of dislodge-
ment (subcutaneous emphysema). 
In conclusion, we have demonstrated 
in a porcine model that the prophylactic 
use of TTJV by using a simple, readily 
available set-up is an efficient method 
for maintaining arterial oxygenation. 
This allows extra time for intubation of 
the trachea either by bronchoscope 
or direct laryngoscopy during “cannot 
intubate, cannot ventilate” scenarios or 
in patients with difficult airway due to 
head or neck trauma.
Figure 3. Maxillofacial trauma algorithm with the two modifications we pro-
pose noted in orange lettering. This flow diagram highlights a subgroup of 
patients where prophylactic TTJV may be of the most benefit. This algorithm 
divides management into life-threatening versus non life-threatening. In non 
life-threatening scenarios it may not be appropriate to use prophylactic TTJV. 
However, in life-threatening situations where airway access is required, 
prophylactic TTJV can be placed safely prior to sedation and loss of airway 
reflexes. When airway is unable to be established, then jet ventilation should 
be initiated while awaiting surgical intervention. Used with permission from 
ASA newsletter. (10)
TTJV, oxygenation drastically improved 
while hypercapnia remained at mod-
est level (45 mmHg) during the same 
time period. Thus, early TTJV prevents 
hypoxemia and provides the anesthesi-
ologist with extra time to provide seda-
tion, perform tracheal intubation or gain 
surgical airway. While arrangements 
for the definitive management of the 
difficult airway (fiberoptic intubation, 
surgical airway) may require some pre-
paratory time, a tracheal catheter for 
jet ventilation can be inserted quickly 
and atraumatically with readily available 
equipment such as 12- or 14-gauge 
angiocatheters. (2) 
Several studies have evaluated the use 
of TTJV in animal models. (4-7) Recently, 
Schaefer et al. demonstrated sufficient 
oxygenation with TTJV in a porcine 
model with a self-made airway device 
similar to the one used in this study. (7) 
Furthermore, clinical use of TTJV dur-
ing the management of difficult airway 
has been reported. (2,8,9) We recently 
reported the usefulness of TTJV placed 
prophylactically in two patients with neck 
and maxillofacial trauma. (2)  Early use 
of TTJV allowed us to maintain adequate 
oxygenation in these uncooperative and 
critically injured patients and permitted 
more time for securing the airway with 
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